HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Torrelo Selected Research

ozenoxacin

4/2021Treatment of Impetigo and Antimicrobial Resistance.
1/2020Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.
1/2019Ozenoxacin: a review of preclinical and clinical efficacy.
10/2018Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Torrelo Research Topics

Disease

9Hemangioma (Angioma)
07/2022 - 09/2010
7Atopic Dermatitis (Atopic Eczema)
02/2022 - 11/2013
5Impetigo (Impetigo Contagiosa)
04/2021 - 10/2018
3Atrophy
01/2021 - 11/2013
3Skin Diseases (Skin Disease)
11/2015 - 09/2006
2Disease Progression
05/2021 - 03/2021
2Neoplasms (Cancer)
03/2021 - 04/2012
2Cysts
03/2021 - 04/2012
2Ectodermal Dysplasia (Aplasia Cutis Congenita)
01/2021 - 11/2011
2Telangiectasis (Telangiectasia)
01/2021 - 11/2013
2Granuloma
07/2020 - 05/2007
2Eczema
09/2018 - 06/2017
2Ichthyosis (Xeroderma)
11/2017 - 03/2016
2Rosacea (Acne Rosacea)
03/2017 - 01/2014
2chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
01/2017 - 03/2012
2Acne Vulgaris
09/2013 - 07/2005
1Systemic Mastocytosis
05/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021
1Fibroma (Fibromatosis)
03/2021
1Actinic Keratosis
03/2021
1Aggressive Fibromatosis (Desmoid)
03/2021
1Brachydactyly
01/2021
1Exanthema (Rash)
01/2021
1Tachycardia (Tachyarrhythmias)
01/2021
1Hyperemia
01/2021
1COVID-19
05/2020
1Chilblains (Chilblain)
05/2020
1Aphthous Stomatitis (Aphthous Ulcer)
11/2019
1Anaphylaxis (Anaphylactic Shock)
05/2019
1Mast Cell Activation Disorders (Mast-Cell Disease)
05/2019
1Mastocytoma
05/2019
1Erythema Multiforme
07/2018
1Hypertrichosis
07/2018
1Thrombocytopenia (Thrombopenia)
11/2017
1Dermatitis
03/2017
1Virus Diseases (Viral Diseases)
01/2017
1Lipodystrophy
11/2015
1Chronic Disease (Chronic Diseases)
11/2015
1Hypersensitivity (Allergy)
07/2015
1Hypotension (Low Blood Pressure)
02/2015
1Bradycardia
02/2015
1Bronchial Spasm
02/2015
1Body Weight (Weight, Body)
02/2015
1Hypoglycemia (Reactive Hypoglycemia)
02/2015
1Angiokeratoma
10/2014
1Vascular Malformations
10/2014
1Lymphomatoid Granulomatosis (Granulomatosis, Lymphomatoid)
03/2014
1Infections
11/2013

Drug/Important Bio-Agent (IBA)

8Propranolol (Inderal)FDA LinkGeneric
07/2022 - 09/2010
4Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 07/2005
4ozenoxacinIBA
04/2021 - 10/2018
3Methotrexate (Mexate)FDA LinkGeneric
03/2021 - 03/2011
3pimecrolimus (Elidel)FDA Link
01/2021 - 11/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
09/2018 - 11/2013
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017 - 03/2012
3Isotretinoin (Accutane)FDA LinkGeneric
01/2014 - 07/2005
2CeramidesIBA
02/2022 - 11/2017
2Biological ProductsIBA
01/2022 - 03/2011
2Adalimumab (Humira)FDA Link
11/2019 - 03/2011
2EnzymesIBA
11/2017 - 03/2010
2Ivermectin (Mectizan)FDA Link
03/2017 - 01/2014
2CollagenIBA
04/2012 - 05/2007
1Timolol (Blocadren)FDA LinkGeneric
07/2022
1dupilumabIBA
01/2022
1tralokinumabIBA
01/2022
1nemolizumabIBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2021
1Sorafenib (BAY 43-9006)FDA Link
03/2021
1C-Reactive ProteinIBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1ParaffinIBA
07/2020
1Proteins (Proteins, Gene)FDA Link
05/2020
1retapamulinFDA Link
01/2020
1QuinolonesIBA
01/2019
1Aligeron (AS 2)IBA
10/2018
1Dinoprostone (PGE2)FDA Link
07/2018
1DNA (Deoxyribonucleic Acid)IBA
07/2018
1Omeprazole (Prilosec)FDA LinkGeneric
07/2018
1methylprednisolone aceponateIBA
06/2017
1EmollientsIBA
06/2017
1InterferonsIBA
01/2017
1Collodion (Nitrocellulose)IBA
03/2016
1Immunoglobulin E (IgE)IBA
07/2015
1AntibodiesIBA
07/2015
125-hydroxyvitamin DIBA
07/2015
1Vitamin DFDA LinkGeneric
07/2015
1AllergensIBA
07/2015
1hydroxide ionIBA
07/2015
1SolutionsIBA
02/2015
1Coloring Agents (Dyes)IBA
10/2014
1Pharmaceutical PreparationsIBA
04/2014
1Rituximab (Mabthera)FDA Link
03/2014
1Tacrolimus (Prograf)FDA LinkGeneric
01/2014
1Doxycycline (Periostat)FDA LinkGeneric
01/2014

Therapy/Procedure

10Therapeutics
07/2022 - 07/2006
1Critical Care (Surgical Intensive Care)
01/2021
1Operative Surgical Procedures
05/2019
1General Anesthesia
05/2019
1Duration of Therapy
01/2018